Home › AmpliPhi BioSciences Cleared To Submit Listing Application To NYSE MKT
 

Keywords :   


AmpliPhi BioSciences Cleared To Submit Listing Application To NYSE MKT

2015-08-05 08:10:14| drugdiscoveryonline Home Page

AmpliPhi BioSciences Corporation, a global leader in developing bacteriophage-based antibacterial therapies to treat drug resistant infections, recently announced that its board of directors has approved a one-for-fifty reverse split of the company’s common stock to become effective at market open on August 07, 2015

Tags: application submit listing cleared

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Weekly Recap: Nippon Paint, AkzoNobel, PPG Top This Weeks Stories
02.11Subtropical Storm Patty Graphics
02.11Subtropical Storm Patty Forecast Discussion Number 1
02.11Subtropical Storm Patty Wind Speed Probabilities Number 1
02.11Subtropical Storm Patty Forecast Advisory Number 1
02.11Subtropical Storm Patty Public Advisory Number 1
02.11Summary for Subtropical Storm Patty (AT2/AL172024)
02.11Tropical Storm Lane Graphics
More »